20502 ⎘
Medicinal preparations containing organic active ingredients; Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
SYNTHETIC ROCAGLATES WITH BROAD-SPECTRUM ANTIVIRAL ACTIVITIES AND USES THEREOF
#2ANTIMICROBIAL COMBINATIONS
#3CATIONIC CHROMENONES AND THEIR USE IN ONCOLOGY
#4BUDESONIDE 21-PHOSPHATE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
#5DRUG COMBINATION FOR TREATMENT OF GASTRIC CANCER
#6DOSE AND REGIMEN FOR A HETEROCYCLIC PHOSPHINIC COMPOUND
#7PHOSPHORUS COMPOUND AND USE THEREOF
#8TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#9COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#10COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE AND FUSOBACTERIA-CAUSED OR RELATED DISEASES AND CONDITIONS
#11ORAL COMPLEMENT FACTOR D INHIBITORS
#12PHENETHYLAMINES AND CATHINONES PRECURSORS
#13SMALL MOLECULE INHIBITORS OF NAV1.8 SODIUM CHANNELS FOR PAIN RELIEF
#14IDURONIDASE STABILIZERS AND USES THEREOF
#15Genistein phosphate derivatives
#16CRK-LIKE (CRKL) ADAPTOR PROTEIN INHIBITORS AND METHODS OF MAKING AND USING THE SAME
#17ORAL DOSAGE FORMS OF TRβ AGONIST VK2809 FOR THE TREATMENT OF LIVER DISORDERS AND METHODS OF PREPARING THE SAME
#18Phenethylamines and cathinones precursors
#19N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO
#20LIGNAN DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF
#21STEROID COMPOUND AND CONJUGATE THEREOF
#22DRUG COMBINATION FOR TREATMENT OF GASTRIC CANCER
#23DELIVERY OF THERAPEUTIC ALKALOID COMPOUNDS
#24SUBSTITUTED TETRAHYDROFURAN-2-CARBOXAMIDES AS MODULATORS OF SODIUM CHANNELS
#25THIOL-BASED MULTIVALENT DRUG DELIVERY COMPOSITIONS
#26NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND THEIR USES
#27Method of Screening Antioxidants
#28ASYMMETRIC GPR84 ANTAGONIST AND USE THEREOF
#29COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY
#30BENZO-RING-CONTAINING DERIVATIVE, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#31COMBINATION THERAPY FOR TREATMENT OF LIVER DISEASES
#32TRAP1 INHIBITOR AND USE THEREOF
#33Prodrugs of Thyroid Hormone Analogs, Methods of Making and Methods of Using Thereof
#34COMBINATION THERAPY EFFECTIVE AGAINST MICROORGANISMS, INCLUDING DRUG RESISTANT MICROORGANISMS
#35COMBINATION THERAPY FOR TREATMENT OF LIVER DISEASES
#36COMBINATION PRODUCT AND METHODS FOR PREVENTING THE EMERGENCE OF ANTIBIOTIC-RESISTANT BACTERIA UNDER ANTIBIOTIC TREATMENT
#37HETEROAROMATIC PHOSPHONIUM SALTS FOR TREATING CANCER
#38CYCLIC PHOSPHONATE COMPOSITION AND PREPARATION METHOD THEREOF
#39COMPOSITIONS FOR THE TREATMENT OF FIBROSIS
#40ASSOCIATIONS OF FOSFOMYCIN AND COLISTIN FOR USE AGAINST BIOFILM-ASSOCIATED BACTERIAL INFECTIONS
#41SPIRAL STEROIDS AND PRECURSORS THEREOF FOR CLINICAL DIAGNOSIS AND TREATMENT OF NECROTIZING ENTEROCOLITIS AND PRE-ECLAMPSIA
#42THERAPEUTIC AGENT FOR PULMONARY FIBROSIS
#43DIAGNOSTIC METHODS FOR T CELL THERAPY
#44Methods of Treatment of Fibrotic Diseases
#45COMBINATION THERAPY FOR TREATING COVID-19
#46Sustained-Release Oral Fosamprenavir Formulation for Treatment of Reflux
#47COMPOSITIONS AND METHODS OF TREATING ACNE AND PHOTOAGING
#48PHARMACEUTICAL COMPOSITIONS, METHOD OF MAKING AND METHOD OF USING THEREOF
#49AUTOPHAGY ACTIVATOR
#50COMPOSITIONS AND METHODS FOR TREATING METABOLIC DYSREGULATION
#51Methods of Identifying Novel Dosing Regimens
#52KILLING SENESCENT CELLS AND TREATING SENESCENCE-ASSOCIATED CONDITIONS USING A SRC INHIBITOR AND A FLAVONOID
#53COMBINATION THERAPY FOR REDUCING DRUG-INDUCED NEPHROTOXICITY, DYSLIPIDEMIA AND HYPERGLYCEMIA
#54Nicotinamide mononucleotide derivatives and their uses
#55BUDESONIDE 21-PHOSPHATE SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
#56Aerosolized Formulations of HIV Protease Inhibitors for the Treatment of Airway Reflux
#57COMBINATION THERAPY FOR TREATING COVID-19
#58Fosfomycin tablet formulations
#59SPINOSYN FORMULATIONS FOR TREATMENT OF DEMODEX-INDUCED OCULAR AND FACIAL CONDITIONS
#60METHODS FOR THE PREPARATION OF RIBOSIDES
#61ANTI-INFLAMMATORY COMPOUNDS FOR USE IN THE TREATMENT OF DERMAL DISORDERS
#62NOVEL ANTIVIRAL COMPOSITIONS FOR TREATING THE FLU
#63COMPOSITIONS AND METHODS TO TREAT NON-ALCOHOLIC FATTY LIVER DISEASES (NAFLD)
#64COMPOSITION COMPRISING AN ANTI-OXIDANT TO PRESERVE CORNEAL TISSUE
#65Combination therapy effective against microorganisms, including drug resistant microorganisms
#66COMPOSITIONS TO PROMOTE THE HEALING OF SKIN ULCERS AND WOUNDS
#67COMPOSITION FOR THE INTRAPERITONEAL TREATMENT OF SECONDARY BACTERIAL PERITONITIS WITH REDUCTION OF COMPLICATIONS
#68Combination comprising zidovudine and an antimicrobial compound
#69METHODS AND COMPOSITIONS FOR TREATING HUMAN PAPILLOMAVIRUS (HPV)-INDUCED CANCERS
#70USE OF P1P DERIVATIVES AS THERAPEUTIC AGENT FOR SEPSIS
#71TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#72Compositions for the treatment of fibrosis and inflammation
#73Sustained release injectable formulation containing a poly L lactic acid filler and a hyaluronic acid filler conjugate and a method for preparing the same
#74Combination therapy for the treatment of liver disease
#75BIOACTIVE VITAMIN COMBINATIONS
#76NOVEL HYDROGEL CONJUGATES
#77ANTIMICROBIAL, BACTERIOPHAGE-DERIVED POLYPEPTIDES AND THEIR USE AGAINST GRAM-NEGATIVE BACTERIA
#78Methods and compositions comprising tyrosine kinase inhibitor and triptolide for the treatment of cancer
#79Pharmaceutical compositions, method of making and method of using thereof
#80Drug-Eluting Spacer for Joints of the Human Body
#81N4-HYDROXYCYTIDINE AND DERIVATIVES AND ANTI-VIRAL USES RELATED THERETO
#82THIOL-BASED MULTIVALENT DRUG DELIVERY COMPOSITIONS
#83COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY
#84Method for treating acute myeloid leukemia
#85COMPOSITIONS FOR TREATING LUNG INFECTIONS BY AIRWAY ADMINISTRATION
#86COMPOSITIONS FOR ELIMINATING BACTERIAL PROMOTORS OF COLORECTAL CANCER BY INTRALUMINAL APPLICATION
#87Methods for treating virus infections
#88COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE AND FUSOBACTERIA-CAUSED OR RELATED DISEASES AND CONDITIONS
#89TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#90Composition and methods of treating acne and photoaging
#91Nicotinamide mononucleotide derivatives and their uses
#92Killing senescent cells and treating senescence-associated conditions using a SRC inhibitor and a flavonoid
#93Compounds, composition and uses thereof for treating cancer
#94Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same
#95Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same
#96Fosfomycin formulation for parenteral administration
#97COMPOSITIONS TO PROMOTE THE HEALING OF SKIN ULCERS AND WOUNDS
#98Methods of identifying dosing regimens
#99METHODS FOR THE PREPARATION OF RIBOSIDES
#100Compositions for the treatment of fibrosis
#101Topical skin care compositions
#102BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES
#103HYDROXY FORMAMIDE DERIVATIVES AND THEIR USE
#104Aziridine containing DNA alkylating agents
#105Combination Therapy for Treating Proliferative Diseases
#106Oat and marigold based composition with anti-inflammatory and wound healing action and method of preparing same
#107Methods for identifying novel dosing regimens
#108Reversal of fosfomycin resistance
#109Therapeutic Combination for the Treatment of Cancer
#110Method of treating glycogen storage disease
#111Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same
#112Pharmaceutical compositions and methods for potentiating gene silencing
#113Method of treating benign prostatic hyperlasia with antibiotics
#114Methods for inhibiting infectious peritonitis
#115Methods for treating filoviridae virus infections
#116Topical skin care compositions
#117Antiviral aryl-amide phosphodiamide compounds
#118Nanocomplex
#119COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY
#120METHOD OF REDUCING THYROID-ASSOCIATED SIDE EFFECTS
#121Methods for Improving Drug Treatments in Mammals
#122USE OF THYROID BETA-AGONISTS
#123COMBINATION THERAPY COMPRISING OXAZOLIDINONE-QUINOLONES FOR USE IN TREATING BACTERIAL INFECTIONS
#124Thyromimetics for the treatment of fatty liver diseases
#125Fosfomycin formulation for parenteral administration
#126TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#127Administration of hypoxia activated prodrugs and antiangiogenic agents for the treatment of cancer
#128VITAMIN E PHOSPHATE OR ACETATE FOR USE IN THE TREATMENT AND PREVENTION OF BIOFILM INFECTIONS
#129COMPOSITIONS AND METHOD FOR REDUCING CARDIOTOXICITY
#130Combination therapy effective against microorganisms, including drug resistant microorganisms
#131Beta-lactamase inhibitors, formulations, and uses thereof
#132THE FORMULATION COMPRISING PHOSPHOMYCINE AND ASCORBIC ACID FOR THE TREATMENT OF BACTERIAL URINARY SYSTEM INFECTIONS
#133Multikinase inhibitors for use in the treatment of cancer
#134Diagnostic methods for T cell therapy
#135Phospholipid ether analogs as cancer-targeting drug vehicles
#136Compositions and methods of treating acne and photoaging
#137Methods for treating Filoviridae virus infections
#138Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
#139COMPOSITIONS FOR TREATING LUNG INFECTIONS BY AIRWAY ADMINISTRATION
#140Combination Therapy for Treating Proliferative Diseases
#141Compositions, kits and methods for ameliorating oculoplastic post-procedural effects
#142Use of ceranib-2 in the treatment of lung cancer
#143PHARMACEUTICAL COMPOSITION, SUBSTRATE COMPRISING A PHARMACEUTICAL COMPOSITION, AND USE OF A PHARMACEUTICAL COMPOSITION
#144Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same
#145Reducing the reproductive capacity of mammals
#146Predictive baseline biomarkers for use of vascular disrupting agents
#147AZIRIDINE CONTAINING DNA ALKYLATING AGENTS
#148Tyrosinase activity inhibitor and external preparation for skin
#149Stable Vitamin C System
#150PYRANONAPHTHOQUINONE COMPOUNDS AND METHODS OF USE THEREOF
#151Fumagillol derivatives
#152Triptolide prodrugs
#153Synthetic glucopyranosyl lipid adjuvants
#154BUFALIN PHOSPHATE PRODRUGS AND METHODS OF USE THEREOF
#155Treatment or prophylaxis of proliferative conditions
#156USE OF HEMOGLOBIN EFFECTORS TO INCREASE THE BIOAVAILABILITY OF THERAPEUTIC GASES
#157Iminosugars and methods of treating viral diseases
#158Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties
#159COMPOSITIONS FOR THE TREATMENT OF PERITONITIS
#160Gold (I)-Phosphine Compounds as Anti-Bacterial Agents
#161Gold (I)-Phosphine Compounds as Anti-Bacterial Agents
#162Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease
#163APPLICATION OF TOPICAL PRODUCT USING A SONIC DEVICE
#164Synthetic glucopyranosyl lipid adjuvants
#165BISMUTH-THIOLS AS ANTISEPTICS FOR AGRICULTURAL, INDUSTRIAL AND OTHER USES
#166COMPOSITION FOR SKIN PENETRATION, CONTAINING CATIONIC MOLECULE TRANSPORTER AND ANIONIC BIOACTIVE MATERIAL
#167Inorganic-organic hybrid compound
#168Thyromimetics for the treatment of fatty liver diseases
#169Composition
#170Method for treating chronic lymphocytic leukemia
#171Composition and methods of treating acne and photoaging
#172COMBINATION THERAPIES TARGETING MITOCHONDRIA FOR CANCER THERAPY
#173COMPOSITIONS FOR TREATING LUNG INFECTIONS BY AIRWAY ADMINISTRATION
#174Method for improving drug treatments in mammals
#175Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
#176Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors
#177COMPOSITIONS TO PROMOTE THE HEALING OF SKIN ULCERS AND WOUNDS
#178Hydroxy formamide derivatives and their use
#179COMPOSITION OF EXCIPIENTS AND PHARMACEUTICAL FORMS WITH SUSTAINED RELEASE AND INCREASED BIOAVAILABILITY OF ANTIBACTERIAL DRUGS, ANTICOCCIDIAL DRUGS AND OTHER DRUGS FOR COMMERCIAL POULTRY AND PIGS
#180Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
#181Predictive biomarker for hypoxia-activated prodrug therapy
#182Phospholipid ether analogs as cancer-targeting drug vehicles
#183HNF4-alpha ANTAGONIST AND USE THEREOF
#184BASE AND EXTERNAL PREPARATION FOR SKIN
#185Fumagillol derivatives
#186Treatment of leukemia with artemisinin derivatives and combinations with other antineoplastic agents
#187Immunosuppressive compounds and therapeutics
#188Diagnosis of respiratory tract infectious disease using urine specimens
#189Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
#190Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
#191Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
#192Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
#193Phospholipid ether analogs as cancer-targeting drug vehicles
#194Phospholipid ether analogs as cancer-targeting drug vehicles
#195Methods for the preparation of ribosides
#196TUMOR ERADICATION BY INOSITOL-TRIPYROPHOSPHATE
#197Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections
#198Triptolide prodrugs
#199SUGAR-ANALOG PHOSPHORUS-CONTAINING HETEROCYCLES HAVING AN ANTI-METASTATIC ACTIVITY
#200Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors
#201Composition and methods used during anti-HIV treatment
#202Spirocyclic sulfones as gamma secretase inhibitors
#203Compositions, kits, and methods for ameliorating oculoplastic post-procedural effects
#204Fosfomycin preparation, a method for producing the preparation, and a polymethylmethacrylate bone cement powder containing the preparation
#205Iminosugars and methods of treating viral diseases
#206Reducing the reproductive capacity of mammals
#207ENDOSPORE COMPOSITIONS AND USES THEREOF
#208MULTIKINASE INHIBITORS FOR USE IN THE TREATMENT OF CANCER
#209Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
#210Pharmaceutical compositions and treatment of mastitis
#211Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
#212ANDROGRAPHOLIDE ANALOGS AND THEIR USE FOR MEDICATION
#213Method for improving drug treatments in mammals
#214COMBINATION THERAPY INVOLVING A VASCULAR DISRUPTING AGENT AND AN AGENT WHICH TARGETS HYPOXIA
#215COMPOSITIONS AND METHODS OF TREATMENT COMPRISING FOSFOMYCIN DISODIUM
#216FORMULATIONS OF AMINOGLYCOSIDE AND FOSFOMYCIN COMBINATIONS AND METHODS AND SYSTEMS FOR TREATMENT OF VENTILATOR ASSOCIATED PNEUMONIA (VAP) AND VENTILATOR ASSOCIATED TRACHEAL (VAT) BRONCHITIS
#217Formulations of aminoglycosides and fosfomycin in a combination having improved chemical properties
#218FUSED AROMATIC PHOSPHONATE DERIVATIVES AS PRECURSORS TO PTP-1B INHIBITORS
#219TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#220Method for Inducing a TRIF-Bias
#221Derivative of butylphthalide and preparation method and use thereof
#222Composition comprising non-neutralised tocol phosphate and a vitamin A compound
#223Combination Therapy for Treating Proliferative Diseases
#224Substituted bisphenyl butanoic phosphonic acid derivatives as NEP inhibitors
#225Formulations of aminoglycoside and fosfomycin in combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
#226Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
#227TUMOR ERADICATION BY INOSITOL-TRIPYROPHOSPHATE
#228Diagnosis of respiratory tract infectious diseases using urine specimens
#229DRY POWDER FOSFOMYCIN/TOBRAMYCIN FORMULATION FOR INHALATION
#230Use of calixarenes associated with an antibiotic in the treatment of bacterial infections
#231USE OF CALIXARENES ASSOCIATED WITH AN ANTIBIOTIC IN THE TREATMENT OF BACTERIAL INFECTIONS
#232POLYMORPHISMS PREDICTIVE OF PLATINUM-COORDINATING COMPLEX INDUCED OTOTOXICITY
#233Gamma secretase inhibitors
#234Esters of 4, 9-dihydroxy-naphtho [2, 3-b] furans for disease therapies
#235Multikinase inhibitors for use in the treatment of cancer
#236Aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
#237Aerosol formulation of aminoglycoside and fosfomycin combination for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
#238COMPOSITIONS AND METHODS OF TREATING GLAUCOMA
#239Skin external preparation and method of producing same
#240Sesterterpene Compounds and Use Thereof
#241Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
#242Iminosugars and methods of treating viral diseases
#243Zanamivir phosphonate congeners with anti-influenza activity and determining oseltamivir susceptibility of influenza viruses
#244PROCESS FOR PREPARATION OF HIV PROTEASE INHIBITORS
#245ANTIMICROBIAL AND VULNERARY ACTION PHARMACEUTICAL COMPOSITION FOR EXTERNAL APPLICATION AND ITS PRODUCTION PROCESS
#246ANTIMICROBIAL AND ANTI-INFLAMMATORY ACTION PHARMACEUTICAL COMPOSITION FOR PARENTERAL ADMINISTRATION AND ITS PRODUCTION PROCESS
#247Assay for measuring inflammatory molecules in orally ingestible samples
#248Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#249Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
#250Combination Therapy Comprising A CCR5 Antagonist, A HIV-1 Protease Inhibtior and a Pharmacokinetic Enhancer
#251Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
#252TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#253Phosphate-containing nanoparticle delivery vehicle
#254Phosphate-containing nanoparticle delivery vehicle
#255Inhibitors of diacylglycerol O-acyltransferase 1 (DGAT-1) and uses thereof
#256Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
#257Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
#258Process for preparation of HIV protease inhibitors
#259Fosfomycin pharmaceutical composition
#260Triptolide prodrugs
#261Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors
#262CRYSTALLINE FORM OF FOSAMPRENAVIR CALCIUM
#263TREATMENT OR PROPHYLAXIS OF PROLIFERATIVE CONDITIONS
#264Compositions and Methods for Selectively Activating Human Sirtuins
#265AMORPHOUS FOSAMPRENAVIR CALCIUM
#266TUMOR ERADICATION BY INOSITOL-TRIPYROPHOSPHATE
#267Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
#268METHOD OF REDUCING MULTI-DRUG RESISTANCE USING INOSITOL TRIPYROPHOSPHATE
#269Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
#270Method for inducing a TRIF-bias
#271FOSFOMYCIN/TOBRAMYCIN COMBINATIONS FOR THE TREATMENT AND PREVENTION OF OPHTHALMIC, OTOLOGICAL AND DERMATOLOGICAL INFECTIONS
#272Methods For Treating Myocardial Disorders
#273Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#274Reduced-odor thiol compositions
#275Combination Therapy for Treating Proliferative Diseases
#276INHALED FOSFOMYCIN/TOBRAMYCIN FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#277Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections
#278Compositions and methods for treating corneal inflammation
#279Analgesic agent comprising cyclic phosphatidic acid derivative
#280PROCESS FOR PREPARATION OF HIV PROTEASE INHIBITORS
#281Methods of treating vasodilatory shock
#282COMPOSITION AND METHODS USED DURING ANTI-HIV TREATMENT
#283PHOSPHORYLATED PYRONE ANALOGS AND METHODS
#284Combination of insulin and ascorbate to enhance wound healing
#285Synthetic glucopyranosyl lipid adjuvants
#286Treatment or prophylaxis of proliferative conditions
#287PHOSPHORYLATED AND PHOSPHONATED PYRONE ANALOGS FOR THERAPEUTIC TREATMENT
#288Phosphaplatins and their use in the treatment of cancers resistant to cisplatin and carboplatin
#289Iminosugars and methods of treating viral diseases
#290Pharmaceutical composition, substrate comprising a pharmaceutical composition, and use of a pharmaceutical composition
#291Substituted phosphonates and their use in decreasing amyloid aggregates
#292PHOSPHORYLATED PYRONE ANALOGS AND METHODS
#293Pyrone analogs for therapeutic treatment
#294PHOSPHORYLATED PYRONE ANALOGS AND METHODS
#295PODOPHYLLOTOXIN INHIBITORS OF TOPOISOMERASE II
#296Hydrous gel and production process and use of the hydrous gel
#297Methods for Treating Cystic Fibrosis or Pneumonia with Bacterial Infection via Pulmonary Administration of Fosfomycin
#298POLYMORPHISMS PREDICTIVE OF PLATINUM-COORDINATING COMPLEX INDUCED OTOTOXICITY
#299RESISTANCE-REPELLENT RETROVIRAL PROTEASE INHIBITORS
#300Substituted benzofurans, benzothiophenes, benzoselenophenes and indoles and their use as tubulin polymerisation inhibitors